Effect of liver failure on the pharmacokinetics of cyclophosphamide
Author:
- 1 January 1984
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 26 (5) , 591-593
Abstract
The pharmacokinetics of cyclophosphamide was investigated in 7 patients in severe liver failure. The pharmacokinetic data were compared with those derived from a matched control group of patients with normal liver function. The half-life (t1/2) of cyclophosphamide following intravenous administration in patients with liver failure was 12.5±1.0 h (m±SD), which was significantly longer than in the normal controls in whom it was 7.6±1.4 h (pt) was significantly smaller in liver failure at 44.8+8.6l·kg−1 than in the controls in whom it was 63.0±7.6l·kg−1 (p<0.01). It is concluded that severe liver disease has a significant effect on the disposition of cyclophosphamide, and that it could lead to accumulation of the drug in the body.Keywords
This publication has 8 references indexed in Scilit:
- Some aspects of the gas—liquid chromatographic analysis of cyclophosphamide in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1980
- [Effect of damaged liver parenchyma, renal insufficiency and hemodialysis on the pharmacokinetics of cyclophosphamide and its activated metabolites].1980
- COMPARATIVE METABOLISM OF 2-[BIS(2-CHLOROETHYL)AMINO]TETRAHYDRO-2H-1,3,2-OXAZAPHOSPHORINE-2-OXIDE (CYCLOPHOSPHAMIDE) AND ITS ENANTIOMERS IN HUMANS1979
- The quantitation by gas chromatography-chemical ionisation-mass spectrometry of cyclophosphamide, phosphoramide mustard and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy1978
- Pharmacokinetics of intravenous cyclophosphamide in man, estimated by gas-liquid chromatographyCancer Chemotherapy and Pharmacology, 1978
- IDENTIFICATION OF ALDOPHOSPHAMIDE AS A METABOLITE OF CYCLOPHOSPHAMIDE INVITRO AND INVIVO IN HUMANS1977
- Cyclophosphamide metabolites and their related compounds. 2. Preparation of an active species of cyclophosphamide and related compoundsJournal of Medicinal Chemistry, 1975
- Clinical pharmacology of cyclophosphamide.1973